Ronald Kirk Huntsman - 20 Jun 2024 Form 4 Insider Report for Vivos Therapeutics, Inc. (VVOS)

Role: Chief Executive Officer, Director
Signature: /s/ Bradford K. Amman as attorney-in-fact for Ronald Kirk Huntsman
Issuer symbol: VVOS
Transactions as of: 20 Jun 2024
Net transactions value: +$47,600
Form type: 4
Filing time: 28 Jun 2024, 20:53:51 UTC
Previous filing: 20 Jun 2023
Next filing: 27 Nov 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	VVOS	Common Stock						3,461	20 Jun 2024	Direct
holding	VVOS	Common Stock						69,600	20 Jun 2024	See footnote	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VVOS	Stock Option (Right to Buy)	Award	$47,600	+20,000	+68%	$2.38	49,334	20 Jun 2024	Common Stock	20,000	$2.38	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held by Coronado V Partners, LLC, of which the Reporting Person is a member and manager.
F2	On June 20, 2024 (the "Grant Date"), the Reporting Person received a grant of 20,000 stock options from the Issuer. One-fifth vested immediately and one-fifth will vest annually on each anniversary of the Grant Date through June 20, 2028.